Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-26T20:37:09.298Z Has data issue: false hasContentIssue false
  • English
  • Français

Efficacy of Pharmacotherapy and Cognitive Therapy, alone and in Combination in Major Depressive Disorder

Published online by Cambridge University Press:  16 April 2020

F. Shamsaei ,
A. Rahimi  and
M.K. Zarabian
F. Shamsaei
Affiliation:
Hamedan University of Medical Sciences, Hamedan, Iran
A. Rahimi
Affiliation:
Hamedan University of Medical Sciences, Hamedan, Iran
M.K. Zarabian
Affiliation:
Hamedan University of Medical Sciences, Hamedan, Iran

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

To assess the efficacy of pharmacotherapy (citalopram) and cognitive therapy, alone or in combination for the treatment of major depressive disorder.

Methods:

This study was a randomised controlled clinical trial. We randomly assigned 120 adults with a major depressive disorder to 8-week treatment with either citalopram, cognitive therapy, or both. Major depressive disorder was diagnosed using DSM-IV criteria. Patients were assessed with the Beck Depression Inventory before and after treatment.

Results:

Statistical analysis showed that cognitive therapy, pharmacotherapy, and combined therapy were effective in the treatment of depression. There was no significant difference between medication and cognitive therapy. Treatment with the cognitive therapy intervention and citalopram combined yielded better responses than treatment with citalopram or cognitive therapy alone.

Type
P01-288
Information
European Psychiatry , Volume 24 , Issue S1: 17th EPA Congress - Lisbon, Portugal, January 2009, Abstract book , January 2009 , 24-E676
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.